116 research outputs found
Aragon workersâ health study â design and cohort description
BACKGROUND: Spain, a Mediterranean country with relatively low rates of coronary heart disease, has a high prevalence of traditional cardiovascular risk factors and is experiencing a severe epidemic of overweight/obesity. We designed the Aragon Workersâ Health Study (AWHS) to characterize the factors associated with metabolic abnormalities and subclinical atherosclerosis in a middle aged population in Spain free of clinical cardiovascular disease. The objective of this paper is to describe the study design, aims and baseline characteristics of participants in the AWHS. METHODS/DESIGN: Longitudinal cohort study based on the annual health exams of 5,400 workers of a car assembly plant in Figueruelas (Zaragoza, Spain). Study participants were recruited during a standardized clinical exam in 2009â2010 (participation rate 95.6%). Study participants will undergo annual clinical exams and laboratory assays, and baseline and triennial collection of biological materials for biobanking and cardiovascular imaging exams (carotid, femoral and abdominal ultrasonography, coronary calcium score, and ankle-arm blood pressure index). Participants will be followed-up for 10âyears. RESULTS: The average (SD) age, body mass index, and waist circumference were 49.3 (8.7) years, 27.7 (3.6) kg/m(2) and 97.2 (9.9) cm, respectively, among males (Nâ=â5,048), and 40.8 (11.6) years, 24.4 (3.8) kg/m(2), and 81.9 (9.9) cm, among females (Nâ=â351). The prevalence of overweight, obesity, current smoking, hypertension, hypercholesterolemia, and diabetes were 55.0, 23.1, 37.1, 40.3, 75.0, and 7.4%, respectively, among males, and 23.7, 8.3, 45.0, 12.1, 59.5, and 0.6%, respectively, among females. In the initial 587 study participants who completed all imaging exams (94.5% male), the prevalence of carotid plaque, femoral plaque, coronary calcium score >1 to 100, and coronary calcium score >100 was 30.3, 56.9, 27.0, and 8.8%, respectively. 67.7% of study participants had at least one plaque in the carotid or femoral arteries. DISCUSSION: Baseline data from the AWHS show a high prevalence of cardiovascular risk factors and of sublinical atherosclerosis. Follow-up of this cohort will allow the assessment of subclinical atherosclerosis progression and the link of disease progression to traditional and emergent risk factors
Registro Español de Trasplante Cardiaco: XXXI Informe Oficial de la AsociaciĂłn de Insuficiencia Cardiaca de la Sociedad Española de CardiologĂa
[Abstract]
Introduction and objectives.
The present report describes the clinical characteristics and outcomes of heart transplants in Spain and updates the data to 2019.
Methods.
We describe the clinical characteristics and outcomes of heart transplants performed in Spain in 2019, as well as trends in this procedure from 2010 to 2018.
Results.
In 2019, 300 transplants were performed (8794 since 1984; 2745 between 2010 and 2019). Compared with previous years, the most notable findings were the decreasing rate of urgent transplants (38%), and the consolidation of the type of circulatory support prior to transplant, with an almost complete disappearance of counterpulsation balloon (0.7%), stabilization in the use of extracorporeal membrane oxygenation (9.6%), and an increase in the use of ventricular assist devices (29.0%). Survival from 2016 to 2018 was similar to that from 2013 to 2015 (P=.34). Survival in both these periods was better than that from 2010 to 2012 (P=.002 and P=.01, respectively).
Conclusions.
Heart transplant activity has remained stable during the last few years, as have outcomes (in terms of survival). There has been a trend to a lower rate of urgent transplants and to a higher use of ventricular assist devices prior to transplant.[Resumen]
IntroducciĂłn y objetivos.
Se presentan las caracterĂsticas clĂnicas y los resultados de los trasplantes cardiacos realizados en España con la actualizaciĂłn correspondiente a 2019.
MĂ©todos.
Se describen las caracterĂsticas clĂnicas y los resultados de los trasplantes cardiacos realizados en 2019, asĂ como las tendencias de estos en el periodo 2010-2018.
Resultados.
En 2019 se realizaron 300 trasplantes (8.794 desde 1984; 2.745 entre 2010 y 2019). Respecto a años previos, los cambios mås llamativos son el descenso hasta el 38% de los trasplantes realizados en código urgente, y la consolidación en el cambio de asistencia circulatoria pretrasplante, con la pråctica desaparición del balón de contrapulsación (0,7%), la estabilización del uso del oxigenador extracorpóreo de membrana (9,6%) y el aumento de los dispositivos de asistencia ventricular (29%). La supervivencia en el trienio 2016-2018 es similar a la del trienio 2013-2015 (p=0,34), y ambas mejores que la del trienio 2010-2012 (p=0,002 y p=0,01 respectivamente).
Conclusiones.
Se mantienen estables tanto la actividad del trasplante cardiaco en España como los resultados en supervivencia en los Ășltimos 2 trienios. Hay una tendencia a realizar menos trasplantes urgentes, la mayorĂa con dispositivos de asistencia ventricular
Registro Español de Trasplante Cardiaco: XXIX Informe Oficial de la SecciĂłn de Insuficiencia Cardiaca de la Sociedad Española de CardiologĂa (1984-2017)
[Resumen] IntroducciĂłn y objetivos. Se actualizan las caracterĂsticas clĂnicas y los resultados de los trasplantes cardiacos realizados en España en el periodo 2008-2017.
MĂ©todos. Se describen las caracterĂsticas de los receptores, los donantes, los procedimientos quirĂșrgicos y los resultados de los trasplantes realizados en 2017 y se ponen en contexto respecto a los del periodo 2008-2016.
Resultados. En 2017 se realizaron 304 trasplantes. Desde 1984, se han realizado 8.173 trasplantes, 2.689 de ellos desde 2008. Para el periodo 2008-2017, se observan tendencias temporales significativas en las caracterĂsticas del receptor (menores resistencias vasculares pulmonares, menos ventilaciĂłn mecĂĄnica previa al trasplante, mayor tasa de diabĂ©ticos y cirugĂa cardiaca previa), el donante (de mĂĄs edad, mĂĄs donantes mujeres y mĂĄs donantes con parada cardiaca) y el procedimiento (menos tiempo de isquemia). En 2017, el 27% de los trasplantes se realizaron previa asistencia ventricular mecĂĄnica (p < 0,001 para la tendencia). En la Ășltima dĂ©cada, se observa una tendencia a una mejor supervivencia.
Conclusiones. La actividad de trasplante cardiaco se estabiliza en alrededor de 300 procedimientos al año. Se extiende el uso de dispositivos de asistencia ventricular antes del trasplante, con tendencia a la mejora de la supervivencia
Malignancy following heart transplantation: differences in incidence and prognosis between sexes â a multicenter cohort study
[Abstract]
Male patients are at increased risk for developing malignancy postheart transplantation (HT); however, real incidence and prognosis in both genders remain unknown. The aim of this study was to assess differences in incidence and mortality related to malignancy between genders in a large cohort of HT patients. Incidence and mortality rates were calculated for all tumors, skin cancers (SCs), lymphoma, and nonskin solid cancers (NSSCs) as well as survival since first diagnosis of neoplasia. 5865 patients (81.6% male) were included. Total incidence rates for all tumors, SCs, and NSSCs were lower in females [all tumors: 25.7 vs. 44.8 per 1000 personâyears; rate ratio (RR) 0.68, (0.60â0.78), P < 0.001]. Mortality rates were also lower in females for all tumors [94.0 (77.3â114.3) vs. 129.6 (120.9â138.9) per 1000 personâyears; RR 0.76, (0.62â0.94), P = 0.01] and for NSSCs [125.0 (95.2â164.0) vs 234.7 (214.0â257.5) per 1000 personâyears; RR 0.60 (0.44â0.80), P = 0.001], albeit not for SCs or lymphoma. Female sex was associated with a better survival after diagnosis of malignancy [logârank p test = 0.0037; HR 0.74 (0.60â0.91), P = 0.004]. In conclusion, incidence of malignancies postâHT is higher in males than in females, especially for SCs and NSSCs. Prognosis after cancer diagnosis is also worse in males
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients
SARS-CoV-2 infection causes an abrupt response by the host immune system, which is largely responsible for the outcome of COVID-19. We investigated whether the specific immune responses in the peripheral blood of 276 patients were associated with the severity and progression of COVID-19. At admission, dramatic lymphopenia of T, B, and NK cells is associated with severity. Conversely, the proportion of B cells, plasmablasts, circulating follicular helper T cells (cTfh) and CD56âCD16+ NK-cells increased. Regarding humoral immunity, levels of IgM, IgA, and IgG were unaffected, but when degrees of severity were considered, IgG was lower in severe patients. Compared to healthy donors, complement C3 and C4 protein levels were higher in mild and moderate, but not in severe patients, while the activation peptide of C5 (C5a) increased from the admission in every patient, regardless of their severity. Moreover, total IgG, the IgG1 and IgG3 isotypes, and C4 decreased from day 0 to day 10 in patients who were hospitalized for more than two weeks, but not in patients who were discharged earlier. Our study provides important clues to understand the immune response observed in COVID-19 patients, associating severity with an imbalanced humoral response, and identifying new targets for therapeutic interventionThe study was funded by grants SAF2017-
82886-R to FS-M from the Ministerio de EconomĂa y Competitividad,
and from âLa Caixa Banking Foundationâ (HR17-00016) to
FS-M. Grant PI018/01163 to CMC and grant PI19/00549 to AA
were funded by Fondo de Investigaciones Sanitarias, Ministerio de
Sanidad y Consumo, Spain. SAF2017-82886-R, PI018/01163 and
PI19/00549 grants were also co-funded by European Regional
Development Fund, ERDF/FEDER. This work has been funded by
grants Fondo Supera COVID (CRUE-Banco de Santander) to FSM,
and âAyuda Covid 2019â from Comunidad de Madri
The Falling Incidence of Hematologic Cancer After Heart Transplantation
[Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the overall effect on incidence in the HT population.
Methods. Comparison of data from the Spanish Post-Heart-Transplantation Tumour Registry for the periods 1991â2000 and 2001â2010.
Results. The incidence among patients who underwent HT in the latter period was about half that observed in the former, with a particularly marked improvement in regard to incidence more than five yr post-HT.
Conclusions. Changes in HT patient management have jointly reduced the risk of hematologic cancer in the Spanish HT population. Long-term risk appears to have benefited more than short-term risk
Autoantibody screening in Guillain-Barré syndrome
Background: Guillain?Barré syndrome (GBS) is an acute inflammatory neuropathy with a heterogeneous presentation. Although some evidences support the role of autoantibodies in its pathogenesis, the target antigens remain unknown in a substantial proportion of GBS patients. The objective of this study is to screen for autoantibodies targeting peripheral nerve components in Guillain-Barré syndrome.
Methods: Autoantibody screening was performed in serum samples from all GBS patients included in the International GBS Outcome study by 11 different Spanish centres. The screening included testing for anti-ganglioside antibodies, anti-nodo/paranodal antibodies, immunocytochemistry on neuroblastoma-derived human motor neurons and murine dorsal root ganglia (DRG) neurons, and immunohistochemistry on monkey peripheral nerve sections. We analysed the staining patterns of patients and controls. The prognostic value of anti-ganglioside antibodies was also analysed.
Results: None of the GBS patients (n = 100) reacted against the nodo/paranodal proteins tested, and 61 (61%) were positive for, at least, one anti-ganglioside antibody. GBS sera reacted strongly against DRG neurons more frequently than controls both with IgG (6% vs 0%; p = 0.03) and IgM (11% vs 2.2%; p = 0.02) immunodetection. No differences were observed in the proportion of patients reacting against neuroblastoma-derived human motor neurons. Reactivity against monkey nerve tissue was frequently detected both in patients and controls, but specific patterns were only detected in GBS patients: IgG from 13 (13%) patients reacted strongly against Schwann cells. Finally, we confirmed that IgG anti-GM1 antibodies are associated with poorer outcomes independently of other known prognostic factor
- âŠ